Cannabis Company SunPure Industries Enters Into First-of-Its-Kind Private-Label Contract-Manufacturing Relationship With Leading American Health and Wellness Silver Nanotech Company
Cannabis company SunPure to bring nano-silver immune-support drink supplements, anti-microbial creams and wound treatment products to Canada
KELOWNA, British Columbia, December 12, 2018 (Newswire.com) - SunPure Industries Ltd. (“SunPure” or the “Company”), an advanced-stage Canadian cannabis company, announced today that the Company has signed the first-of-its-kind private-label contract-manufacturing relationship (the “Agreement”) with American Biotech Labs LLC (“ABL”) for first-mover access to ABL’s proprietary, highly bio-available silver nanotechnology-based Health Canada-approved Natural Health Products (NHPs), including dietary drink supplements, anti-microbial wound care creams and gels, cosmetic creams and lotions and medical devices for commercialization in Canada and abroad.
ABL is a leading American health and wellness biotech company innovating bio-medical silver nanotechnology-based products for the medical and health industries. The private-label Supply and Distribution Agreement provides SunPure with access to ABL’s patented and government-cleared product lines. The products are approved by Health Canada, have been assigned Natural Product Numbers (NPN) and are licensed for sale under Health Canada’s Natural and Non-prescription Health Products Directorate (NNHPD).
SunPure will begin offering these award-winning products containing ABL's SilverSol Technology® to its customers in the early part of 2019. All products utilize ABL’s ground-breaking patented silver nano-catalytic technology and are specifically formulated to provide highly bio-available, anti-microbial health benefits. All products are licensed for sale by Health Canada as Natural Health Products. Products will include:
- Nano-silver suspension dietary supplements used for immune system support and improved gut-health
- Hydrogel creams that boast regulatory clearance for wound-healing, anti-inflammatory and broad-based anti-microbial/anti-bacterial disinfectant claim-language
- A brand new, lyophilized anti-microbial hyaluronic acid cosmetic facial cream and lotion containing bioactive silver hydrosol for superior absorption and natural healing
"We are very excited to be introducing this superior silver nanotechnology into Canada. We are bringing world-class, verifiable value-added benefits to our Canadian customers via a robust range of Health Canada-approved drink supplements, wound-care creams and cosmetic moisturizing lotions and creams made with the anti-microbial, pathogen-free healing power of nano-silver,” said Mike Mueller, co-founder and CEO, SunPure. “We expect that the Cannabis Act will begin regulating consumer products containing cannabis concentrates in late 2019, at which time SunPure will begin production of cannabis-infused versions of these same incredible anti-microbial products through a partnership with one of Canada’s newest, state-of-the-art ISO 13485 and EU-GMP certified processing and packaging facilities in B.C., which will hold a Standard Processor License under the Cannabis Act. Until then, this agreement gives consumers the opportunity to become familiar with many of ABL's 'family first line of defence products' in advance of their future formulation with SunPure cannabis concentrates."
"SunPure is proud to be the first Canadian cannabis company to have gained access to the right to utilize ABL's proprietary silver nanotechnology in cosmetic products, wound-care creams and drink supplements, all already licensed by Health Canada's Natural and Non-prescription Health Products Directorate (NNHPD) and holding Natural Product Numbers (NPNs),” said Robin Shugar, J.D., Chief Commercial Officer, SunPure. “With the anticipated arrival of Canada's regulations for cannabis-infused consumer goods, being the first cannabis company to bring this superior silver nano-technology to the Canadian market for eventual use in CBD-infused anti-microbial cosmetic and wound-care creams, hand and body lotions, drink supplements and additional health products provides a competitive advantage to SunPure. The ability to combine ABL’s highly differentiated, patented, scientifically proven, value-added nano-tech products with our own CBD-derivatives enables us to capture a larger share of the cannabis-infused CPG market segment.”
“Our unique, proven safe and effective, probiotic-friendly nano-silver products are among the first moisturizing creams and lotions in the world to gain Health Canada regulatory clearance for specific anti-microbial, wound healing/wound treatment benefits,” said Dr. Keith Moeller, CEO, American Biotech Labs LLC. “We have been able to achieve these amazing results without the use of any chemical stabilizers or preservatives, which is a hugely important issue in the cosmetics marketplace. I am confident that this unique combination of features and benefits will allow SunPure to successfully market a highly differentiated product line which will help to satisfy many of its customers' needs and wants.”
About SunPure Industries Ltd.
SunPure is a cannabis cultivation company in the advanced licensing stage under Canada's Cannabis Act and is located in British Columbia’s Okanagan Valley on a founder-funded 40-acre agricultural land package. The land boasts unlimited free-flowing water from an underground Artesian Water Aquifer system, natural gas service and a dedicated 3-phase electrical service which will be upgraded to 1,000 AMPS of 3-phase power. Upon the closing of its initial round of financing, SunPure is set to begin construction on its phase one 13,608-square-foot greenhouse and is targeting a 35-acre outdoor seeding of industrial hemp for CBD extraction Q2 2019 through a contract Hemp Grower Agreement which will provide for complete operational production and harvesting. SunPure is founder-funded to date, which includes land acquisition and all site construction costs.
For further information about SunPure Industries, please visit the Company's website at https://www.sunpure.ca.
|On Behalf of the Board of Directors||For further information or for Investor Deck|
|Mike Mueller||Contact Robin Shugar, J.D.|
|President and Chief Executive Officer||Chief Commercial Officer and Legal Council|
About American Biotech Labs LLC
ABL is a health and wellness biotech company innovating bio-medical silver nanotechnology-based products for the medical and health industries. It holds 58 patents, with additional patents pending. ABL’s award-winning products containing its patented SilverSol Technology® have received numerous FDA clearances and include some of the strongest wound care and antibacterial claims issued by the FDA. ABL invests heavily in science, currently boasting a portfolio of more than 400 major studies and reports. A new published peer-reviewed paper has just proven the proprietary nano-silver’s ability to kill multi-drug-resistant bacteria and eliminate biofilms. Innovation continues and the management of ABL believes that the new relationship with SunPure will lead to new market-superior cannabis/silver-based products.
For more information about American Biotech Labs, please visit silverbiotics.com.
This news release contains forward-looking statements, which relate to predictions of future events or future performance and reflect management's current expectations and assumptions based on information currently available to the Company. "Forward-looking information" within the meaning of applicable securities law ("forward-looking statements") are frequently characterized by words such as "plan," "continue," "expect," "project," "intend," "believe," "anticipate," "estimate," "may," "will," "potential," "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Readers are cautioned that the forward-looking statements throughout this news release are neither promises nor guarantees, and are subject to a variety of risks and uncertainties that may cause future results to differ materially from those expected or projected in the forward-looking statements herein. These forward-looking statements are made as of the date hereof and the Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law. This news release does not constitute an offer to sell securities and the Company is not soliciting an offer to buy securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.
Source: SunPure Industries Ltd.